These findings suggested that the MALAT1 m6A level was upregulated due to the recruitment of the METTL3/METTL14/WTAP methylation complex in HBV/HBx-related HCC cells, with specific binding at m6A sites identified as 6021A and 7265A. The gene discussed is MALAT1; the disease is hepatocellular carcinoma.